HSA/FSA-eligible products available
Call us
Medical Supplies for Home
#1001204466 | Mfg #L031-118B5-300 | Clinical Laboratory

Rapid Test Kit FlowFlex™ Antigen Detection COVID-19 Antigen OTC Nasal Swab Sample 300 Tests per Case / 1 Test per Box

TEST KIT, COVID-19 FLOWFLEX ANTIGEN OTC (300TEST/CS)
Rapid Test Kit FlowFlex™ Antigen Detection COVID-19 Antigen OTC Nasal Swab Sample 300 Tests per Case / 1 Test per Box

Flowflex Covid-19 Antigen Home test is for use under an FDA EUA: https://www.fda.gov/medical-devices/coronavirus-disease-2019-covid-19-emergency-use-authorizations-medical-devices/in-vitro-diagnostics-euas-antigen-diagnostic-tests-sars-cov-2

Product Specifications

MSFH #
1001204466
Manufacturer #
L031-118B5-300
Brand
Acon Laboratories, FlowFlex™, China
Manufacturer
Rapid Test Kit
Country of Origin
Case of 300 Boxes
Application
each Box containing: Test Cassette, Disposable Nasal Swab
Contents 1
Extraction Buffer Tube and Package Insert
HCPCS
U0002
Number of Tests
300 Tests per Case / 1 Test per Box
Product Dating
MSFH Acceptable Dating: we will ship >= 30 days
Reading Type
Visual Read
Sample Type
Nasal Swab Sample
Test Format
Cassette Format
Test Method
Lateral Flow Chromatographic Immunoassay
Test Name
COVID-19 Antigen OTC
Test Type
Antigen Detection
Time to Results
15 Minute Results
UNSPSC Code
41116205

Description

Product ships with minimum 30 days dating

Qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in anterior nasal swab specimens directly from individuals within 7 days of symptom onset or without symptoms or other epidemiological reasons to suspect COVID-19 infection

This test is authorized for non-prescription home use with self-collected anterior nasal swab specimens directly from individuals aged 14 years and older or with adult-collected anterior nasal samples directly from individuals aged 2 years or older

Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status

Positive results do not rule out bacterial infection or co-infection with other viruses

Individuals who test positive should self-isolate and consult their healthcare provider as additional testing may be necessary and for public health reporting

Negative results are presumptive, and confirmation with a molecular assay, if necessary for patient management, may be performed

Negative results should be considered in the context of an individual’s recent exposures, history and the presence of clinical signs and symptoms consistent with COVID-19

Clinical performance showed 93% sensitivity and 100% specificity

Customer Reviews

No reviews yet. Be the first to review this product.

Write a Review

Used to verify your review and never shown to other customers.